P Geusens Selected Research

P Geusens Research Topics

Disease

16	Osteoporosis 12/2020 - 10/2000
13	Rheumatoid Arthritis 01/2019 - 11/2000
4	Postmenopausal Osteoporosis 12/2017 - 12/2001
3	Osteoporotic Fractures 10/2020 - 03/2005
3	Metabolic Bone Diseases (Osteopenia) 04/2004 - 02/2001
3	Bone Resorption 12/2001 - 11/2000
2	Rheumatic Diseases (Rheumatism) 01/2015 - 07/2007
2	Joint Diseases (Joint Disease) 01/2015 - 01/2006
2	Ankylosing Spondylitis 07/2011 - 08/2008
2	Back Pain (Backache) 12/2009 - 01/2001
2	Necrosis 07/2007 - 12/2003
1	Wounds and Injuries (Trauma) 10/2020
1	Inflammation (Inflammations) 12/2017
1	Sarcoidosis (Schaumann Disease) 10/2017
1	Multiple Myeloma 07/2015
1	Stress Fractures (Stress Fracture) 07/2015
1	Osteomalacia 07/2015
1	Hypersensitivity (Allergy) 07/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2009
1	Body Weight (Weight, Body) 04/2008
1	Psoriatic Arthritis 08/2007
1	Infections 07/2007
1	Knee Osteoarthritis 01/2007
1	Hip Osteoarthritis (Coxarthrosis) 01/2007
1	Osteoarthritis 01/2007
1	congenital Sucrase-isomaltase deficiency 04/2006
1	Arthritis (Polyarthritis) 01/2006
1	Congenital Abnormalities (Deformity) 01/2006
1	Tuberculosis (Tuberculoses) 12/2003
1	Synovitis 09/2003
1	Disease Progression 12/2001
1	Neurologic Manifestations (Neurological Manifestations) 01/2001
1	Vitamin D Deficiency 11/2000

Drug/Important Bio-Agent (IBA)

6	GlucocorticoidsIBA 10/2017 - 01/2001
4	Risedronic Acid (Actonel)FDA LinkGeneric 10/2020 - 02/2001
4	Biomarkers (Surrogate Marker)IBA 12/2017 - 09/2003
3	Methotrexate (Mexate)FDA LinkGeneric 01/2015 - 11/2001
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 12/2009 - 11/2001
3	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2006 - 01/2001
2	MineralsIBA 12/2020 - 07/2003
2	Diphosphonates (Bisphosphonates)IBA 04/2019 - 03/2007
2	Antirheumatic Agents (DMARD)IBA 01/2019 - 07/2007
2	Denosumab FDA Link 12/2017 - 10/2015
2	Prednisolone (Predate)FDA LinkGeneric 10/2017 - 11/2001
2	ametantrone (HAQ)IBA 01/2015 - 07/2007
2	Prednisone (Sone)FDA LinkGeneric 01/2015 - 01/2006
2	Infliximab (Remicade)FDA Link 07/2011 - 08/2007
2	Collagen Type II (Type II Collagen)IBA 01/2006 - 09/2003
2	Vitamin D FDA LinkGeneric 07/2003 - 11/2000
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2001 - 11/2000
1	Teriparatide (Parathar)FDA Link 10/2020
1	Biological ProductsIBA 01/2019
1	Phosphates (Orthophosphate)IBA 07/2015
1	Calcitriol (Calcijex)FDA LinkGeneric 07/2015
1	Leflunomide (Arava)FDA LinkGeneric 01/2015
1	W 7 (W7)IBA 01/2015
1	C-Reactive ProteinIBA 01/2015
1	Tumor Necrosis Factor InhibitorsIBA 07/2007
1	Adalimumab (Humira)FDA Link 07/2007
1	Immunologic Factors (Immunomodulators)IBA 07/2007
1	Pharmaceutical PreparationsIBA 01/2007
1	Celecoxib (Celebrex)FDA Link 01/2007
1	SiliconIBA 04/2006
1	Collagen Type I (Type I Collagen)IBA 01/2006
1	Rheumatoid FactorIBA 01/2006
1	lumiracoxib (prexige)IBA 11/2004
1	Raloxifene Hydrochloride (Evista)FDA Link 04/2004
1	Bone Density Conservation AgentsIBA 04/2004
1	Isoniazid (Ftivazide)FDA LinkGeneric 12/2003
1	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 07/2003
1	Peptides (Polypeptides)IBA 12/2001
1	AutoantigensIBA 12/2001
1	CalciumIBA 11/2000
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2000
1	Etidronic Acid (HEDP)FDA LinkGeneric 10/2000

Therapy/Procedure

12	Therapeutics 01/2018 - 11/2001
1	Fracture Fixation 10/2015
1	Drug Therapy (Chemotherapy) 07/2015
1	Remission Induction 01/2015
1	Replacement Arthroplasty 12/2009
1	Chemoprevention 12/2003
1	Immunotherapy 12/2001